Riggs Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-21
Closed -$183 – 778
2025
Q2
$183 Hold
21
– – ﹤0.01% 894
2025
Q1
$168 Hold
21
– – ﹤0.01% 623
2024
Q4
$196 Hold
21
– – ﹤0.01% 632
2024
Q3
$193 Hold
21
– – ﹤0.01% 622
2024
Q2
$206 Hold
21
– – ﹤0.01% 633
2024
Q1
$318 Hold
21
– – ﹤0.01% 612
2023
Q4
$453 Hold
21
– – ﹤0.01% 389
2023
Q3
$391 Hold
21
– – ﹤0.01% 395
2023
Q2
$532 Hold
21
– – ﹤0.01% 362
2023
Q1
$544 Buy
+21
New +$562 ﹤0.01% 337
2022
Q2
– Sell
-42
Closed -$3K – 334
2022
Q1
$3K Buy
42
+2
+5% +$144 ﹤0.01% 284
2021
Q4
$4K Sell
40
-14
-26% -$1.67K ﹤0.01% 283
2021
Q3
$7K Buy
54
+18
+50% +$2.62K ﹤0.01% 249
2021
Q2
$6K Hold
36
– – ﹤0.01% 255
2021
Q1
$7K Hold
36
– – ﹤0.01% 230
2020
Q4
$7K Buy
+36
New +$7.32K ﹤0.01% 213
2020
Q3
– Sell
-36
Closed -$6K – 252
2020
Q2
$6K Sell
36
-11
-23% -$1.93K ﹤0.01% 195
2020
Q1
$7K Buy
+47
New +$5.47K ﹤0.01% 190

Other funds holding TDOC

Riggs Asset Management's TDOC Position: Q3 2025 in Review

Riggs Asset Management sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 21 shares — an estimated $183 sold.

Riggs Asset Management first reported a position in TDOC in Q1 2020 and held it in 18 quarters. The position peaked at $7K in Q3 2021. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Riggs Asset Management reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 21 Teladoc Health shares in Q3 2025, an estimated $183.
  • Riggs Asset Management first reported a position in Teladoc Health in Q1 2020 and held it in 18 quarters.
  • Riggs Asset Management's Teladoc Health position peaked at $7K in Q3 2021.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.